Tylosin Tartrate (CAS 74610-55-2) stands as a cornerstone in modern veterinary medicine, widely recognized for its efficacy as a macrolide antibiotic. Presented typically as a white powder with an assay of ≥98.0% purity, this compound is indispensable for maintaining the health and productivity of various livestock, particularly poultry and swine, and even finding specialized applications in companion animals.

The therapeutic action of Tylosin Tartrate stems from its classification as a macrolide antibiotic. Like other members of this class, it exerts a bacteriostatic effect by selectively interfering with bacterial protein synthesis. Specifically, Tylosin Tartrate binds reversibly to the 23S rRNA of the 50S ribosomal subunit within susceptible bacterial cells. This binding action inhibits the elongation of peptide chains, thereby preventing the bacteria from producing essential proteins required for their growth and replication. This mechanism allows the animal's immune system to more effectively clear the infection, making it a powerful tool in disease management.

One of the primary applications of Tylosin Tartrate is in poultry health. It is widely approved and used for the control and prevention of mycoplasmosis, a group of chronic respiratory diseases caused by Mycoplasma species, such as Mycoplasma gallisepticum and Mycoplasma synoviae. These infections can lead to significant economic losses in poultry farming due to reduced egg production, poor growth rates, and increased mortality. Tylosin Tartrate helps to mitigate these challenges, ensuring healthier flocks and more sustainable operations.

In swine health, Tylosin Tartrate plays an equally crucial role. It is highly effective in the treatment and control of porcine proliferative enteropathies (PPE), commonly known as ileitis, which is associated with Lawsonia intracellularis infection. This condition causes intestinal inflammation, leading to diarrhea, poor weight gain, and reduced feed efficiency. Tylosin Tartrate is also indicated for swine dysentery (SD) associated with Brachyspira hyodysenteriae. Its broad spectrum of activity further extends to controlling various swine respiratory diseases (SRD) caused by pathogens like Bordetella bronchiseptica, Haemophilus parasuis, Pasteurella multocida, Streptococcus suis, and Mycoplasma hyopneumoniae. By addressing these prevalent diseases, Tylosin Tartrate contributes significantly to better herd health and improved production parameters.

Beyond livestock, Tylosin Tartrate has also gained recognition for its distinctive properties in companion animal care. While typically considered an off-label use, veterinarians frequently utilize Tylosin for its anti-inflammatory effects on the gastrointestinal tract, particularly in treating chronic diarrhea, colitis, and inflammatory bowel disease (IBD) in dogs and cats. Its ability to soothe the large intestine makes it a valuable option for long-term management of these conditions, providing relief and improving the quality of life for pets.

The consistent high purity of Tylosin Tartrate, typically at least 98.0%, is critical for its reliable therapeutic performance. When sourcing this vital pharmaceutical ingredient, it is paramount to engage with a reputable manufacturer or supplier who adheres to stringent quality control standards. Proper storage is also essential to maintain its stability and effectiveness; it should be stored in a clean, dry, and cool place, protected from direct sunlight and rain. For those looking to buy or purchase this product, considering the reputation and reliability of the supplier is crucial for ensuring the quality and safety of the veterinary medications. Understanding the price structure and exploring various procurement options from trusted partners can help optimize supply chain efficiency and cost-effectiveness for animal health product formulators and distributors.